Barr Laboratories announced the FDA approved its generic version of Akzo Nobel's Remeron, a drug to treat depression. With the approval, Barr has exclusive rights to sell its Soltab in the U.S. for the next six months.
Published in Brief:
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan